PhD Studentship : Epigenetic Mechanisms in Stem Cell Models of Rett Syndrome

About the GW4 BioMed2 Doctoral Training Partnership

The partnership brings together the Universities of Bath, Bristol, Cardiff (lead) and Exeter to develop the next generation of biomedical researchers. Students will have access to the combined research strengths, training expertise and resources of the four research-intensive universities, with opportunities to participate in interdisciplinary and 'team science'. The DTP already has over 90 studentships over 6 cohorts in its first phase, along with 58 students over 3 cohorts in its second phase.

Project Information

Research Theme: Neuroscience & Mental Health

Summary: Rett syndrome (RTT) is a neurodevelopmental disorder that causes physical and mental disability from early childhood. It is characterised by impaired motor and cognitive function and autistic-like behaviours. We have begun to appreciate that gene regulatory elements called enhancers are perturbed in RTT, but the precise mechanisms involved remain unclear. This project will investigate how mutations in the epigenetic regulator MeCP2 that are associated with RTT lead to changes in enhancer activity in human stem cell models. Using state-of-the-art sequencing technologies, the student will profile chromatin structure and epigenetic marks during neural differentiation and identify regulatory mechanisms that drive RTT.

Project Description: The human genome encodes hundreds of thousands of gene regulatory elements called enhancers. Enhancers are activated cell type-specifically to ensure that different cell types express a unique subset of active genes, thereby playing a central role in gene expression in human development and disease. Their dysregulation is increasingly implicated in neurodevelopmental disorders, but the mechanisms involved are poorly understood. The overall goal of this project is to address this gap. Rett syndrome (RTT) is a neurodevelopmental disorder characterised by impaired motor and cognitive function and autistic-like behaviours. It is caused by mutations in the gene encoding MeCP2, which is expressed at very high levels in neurons where it binds to epigenetic DNA modifications present on enhancers. Recent models propose that MeCP2 mutations cause RTT by disrupting enhancer activity, highlighting the importance of studying the underlying mechanisms involved. Human-induced pluripotent stem cell (hiPSC) lines carrying specific mutations in MeCP2 provide a powerful model to study RTT, as they can be differentiated into neurons and compared to control cell lines with the same genetic background. The aim of this project is to use hiPSC models to understand how MeCP2 mutations disrupt enhancer activity during neural differentiation.

Advert information